John Fesko, President and Chief Business Officer of Natera, Inc. (NASDAQ:NTRA), a $22.1 billion market cap company that has ...

Venture said in a recent regulatory filing that it’s developing five natural gas liquefaction and export projects in ...

Shares of liquefied natural gas exporter Venture Global finished Friday's first day of trading below their initial public ...

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on Natural Gas ...

Venture Global, a producer of liquified natural gas, made its stock market debut on Friday as President Trump plans to boost ...

The Trump administration has made very clear they support growing LNG exports,” Venture CEO Mike Sable told CNBC in an ...

Stephen Charles Taylor, a director at Natural Gas Services Group Inc . (NYSE:NGS), recently sold shares of the company's common stock valued at approximately $558,648, according to a Form 4 filing ...

The U.S. market "could be much bigger than we thought," Reitzes wrote, noting that most of the Stargate spending seems incremental to Nvidia. By his math, even $20 billion in additional spending on ...

Tempus AI (TEM) announced the national launch of the company’s FDA-approved, NGS-based in vitro diagnostic device, xT CDx. Beginning today, xT ...

T CDx is a 648-gene next-generation sequencing test for solid tumor profiling, which includes microsatellite instability ...

The company said, “The Long-Range Plan builds upon the successful execution of the previous three years. NeoGenomics (NEO) intends to achieve ...

(“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading oncology testing services company, today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan. “We enter ...